Novo Nordisk NewsLatest News On Novo Nordisk Novo Nordisk Shares Surge as Fourth-Quarter Earnings Beat Expectations2/5/2025 5:15 PM Novo Nordisk Reports Strong Q4 Earnings Fueled by Wegovy Demand, But Forecasts Slower Sales Growth in 20252/5/2025 3:18 AM Novo Nordisk Beats Profit Expectations Fueled by Wegovy Demand, but Forecasts Slower Growth2/5/2025 3:16 AM Novo Nordisk Surpasses Expectations with Wegovy Sales, CagriSema Trial Results Underwhelm2/5/2025 1:22 AM The Moral Dilemma of a Weight-Loss Drug Empire1/31/2025 12:13 AM FDA Approves Ozempic for Chronic Kidney Disease and Diabetes1/28/2025 5:27 PM FDA Approves Ozempic for Chronic Kidney Disease and Diabetes, Expanding Treatment Options1/28/2025 5:27 PM Ozempic Approved By FDA For Kidney Disease—In Ultra-Popular Drug’s Latest Approval1/28/2025 5:12 PM Boeing, Novo Nordisk, and Twilio Lead Premarket Movers1/24/2025 10:35 AM Novo Nordisk's Amycretin Obesity Drug Shows Promising Early Results, Shares Surge1/24/2025 10:15 AM Novo Nordisk's Amycretin Shows Promising Weight Loss Results in Early Trials1/24/2025 6:56 AM Novo Nordisk's Amycretin Shows Promising Early Results for Obesity Treatment1/24/2025 6:54 AM Novo Nordisk Shares Surge on Promising Obesity Drug Results1/24/2025 6:32 AM Novo Nordisk's Amycretin Shows Promise in Early Obesity Trial1/24/2025 5:40 AM Biden Administration Announces Next 15 Drugs for Medicare Price Negotiations1/17/2025 6:49 PM US to Negotiate Prices for Novo Nordisk's Ozempic and Wegovy1/17/2025 3:16 PM Biden Administration Unveils Next 15 Drugs for Medicare Price Negotiations1/17/2025 11:45 AM Medicare to Implement Price Controls on 15 High-Cost Drugs, Including Novo Nordisk's Wegovy and Ozempic1/17/2025 11:40 AM The Miracle Molecule and the Morality of Weight Loss1/13/2025 8:38 PM Ozempic May Cause Eye-Rotting Condition Leading to Blindness12/24/2024 7:46 AM
